Literature DB >> 21925306

Evolutionary mechanisms and diversity in cancer.

Henry H Q Heng1, Joshua B Stevens, Steven W Bremer, Guo Liu, Batoul Y Abdallah, Christine J Ye.   

Abstract

The recently introduced genome theory of cancer evolution provides a new framework for evolutionary studies on cancer. In particular, the established relationship between the large number of individual molecular mechanisms and the general evolutionary mechanism of cancer calls upon a change in our strategies that have been based on the characterization of common cancer gene mutations and their defined pathways. To further explain the significance of the genome theory of cancer evolution, a brief review will be presented describing the various attempts to illustrate the evolutionary mechanism of cancer, followed by further analysis of some key components of somatic cell evolution, including the diversity of biological systems, the multiple levels of information systems and control systems, the two phases (the punctuated or discontinuous phase and gradual Darwinian stepwise phase) and dynamic patterns of somatic cell evolution where genome replacement is the driving force. By linking various individual molecular mechanisms to the level of genome population diversity and tumorigenicity, the general mechanism of cancer has been identified as the evolutionary mechanism of cancer, which can be summarized by the following three steps including stress-induced genome instability, population diversity or heterogeneity, and genome-mediated macroevolution. Interestingly, the evolutionary mechanism is equal to the collective aggregate of all individual molecular mechanisms. This relationship explains why most of the known molecular mechanisms can contribute to cancer yet there is no single dominant mechanism for the majority of clinical cases. Despite the fact that each molecular mechanism can serve as a system stress and initiate the evolutionary process, to achieve cancer, multiple cycles of genome-mediated macroevolution are required and are a stochastically determined event. Finally, the potential clinical implications of the evolutionary mechanism of cancer are briefly reviewed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21925306     DOI: 10.1016/B978-0-12-387688-1.00008-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  30 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

2.  Unstable genomes elevate transcriptome dynamics.

Authors:  Joshua B Stevens; Guo Liu; Batoul Y Abdallah; Steven D Horne; Karen J Ye; Steven W Bremer; Christine J Ye; Stephen A Krawetz; Henry H Heng
Journal:  Int J Cancer       Date:  2014-05-01       Impact factor: 7.396

3.  Single cell heterogeneity: why unstable genomes are incompatible with average profiles.

Authors:  Batoul Y Abdallah; Steven D Horne; Joshua B Stevens; Guo Liu; Andrew Y Ying; Barbara Vanderhyden; Stephen A Krawetz; Root Gorelick; Henry Hq Heng
Journal:  Cell Cycle       Date:  2013-10-01       Impact factor: 4.534

Review 4.  Evolution of the cancer genome.

Authors:  Ondrej Podlaha; Markus Riester; Subhajyoti De; Franziska Michor
Journal:  Trends Genet       Date:  2012-02-16       Impact factor: 11.639

5.  Identifying early events of gene expression in breast cancer with systems biology phylogenetics.

Authors:  M S Abu-Asab; N Abu-Asab; C A Loffredo; R Clarke; H Amri
Journal:  Cytogenet Genome Res       Date:  2013-04-03       Impact factor: 1.636

6.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 7.  Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos.

Authors:  Tamara A Potapova; Jin Zhu; Rong Li
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 8.  The rise of genomic profiling in ovarian cancer.

Authors:  Rebecca A Previs; Anil K Sood; Gordon B Mills; Shannon N Westin
Journal:  Expert Rev Mol Diagn       Date:  2016-12       Impact factor: 5.225

9.  DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes.

Authors:  Lin Liu; Subhajyoti De; Franziska Michor
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Immortality of cancers: a consequence of inherent karyotypic variations and selections for autonomy.

Authors:  Peter Duesberg; Amanda McCormack
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.